clinical trial · NCT06553625
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Parkinson DiseaseDystoniaEssential TremorMovement DisordersRadiofrequency Ablation
brief summary
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
started
Jan 29, 2024
primary completion
Dec 1, 2035
completion
Dec 1, 2035
last updated
May 7, 2026
detailed description
The objective of this study is to compile real-world outcomes of Boston Scientific Corporation commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
official title
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol